论文部分内容阅读
目的:观察京必舒新(辛伐他汀片,浙江新京药业生产)治疗冠心病合并高脂血症的临床疗效。方法:对48例冠心病合并高脂血症患者采用京必舒新治疗,一疗程(7周),观察临床症状,心率、血压、TC、 TG、LDL-C、HDL-C、肝、肾功能等变化。结果:总有效率 91．7％;京必舒新可以明显改善TC、TG、LDL-C、HDL-C水平,治疗前后比较P<0．05,或P<0．01。治疗期间未见明显不良反应。结论:京必舒新是治疗冠心病合并高脂血症的有效药物。
Objective: To observe the clinical efficacy of Jingbishuxin (simvastatin tablets, Zhejiang Xinjing Pharmaceutical) in the treatment of coronary heart disease complicated with hyperlipidemia. Methods: 48 patients with coronary heart disease complicated with hyperlipidemia were treated with Jingbishuxin for one week. The clinical symptoms, heart rate, blood pressure, TC, TG, LDL-C, HDL-C, Function changes. Results: The total effective rate was 91.7%. Jingbishuxin significantly improved the level of TC, TG, LDL-C and HDL-C, P <0.05 or P <0.01 before and after treatment. No significant adverse reactions during treatment. Conclusion: Jingbishuxin is an effective drug for the treatment of coronary heart disease complicated with hyperlipidemia.